Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort

Cancer Causes and Control

Volumn 23, Issue 3, 2012, Pages 487-496

  Brinton, Louise A ^a   Schwartz, Lauren ^a   Spitz, Margaret R ^b   Park, Yikyung ^a   Hollenbeck, Albert R ^c   Gierach, Gretchen L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c AARP   (United States)

Author keywords

Histology; Lung cancer; Menopausal hormone therapy; Risk

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGED; ARTICLE; BODY SIZE; CANCER INCIDENCE; CANCER RISK; CIGARETTE SMOKING; DRUG USE; ESTROGEN THERAPY; FEMALE; HORMONAL THERAPY; HUMAN; LARGE CELL CARCINOMA; LONG TERM CARE; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; PRIORITY JOURNAL; SELF REPORT; TREATMENT DURATION; UNDIFFERENTIATED CARCINOMA;

AGED; CONFIDENCE INTERVALS; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH (U.S.); PROGESTINS; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RISK; RISK ASSESSMENT; STATISTICS AS TOPIC; UNITED STATES;

EID: 84862821253     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-9904-2     Document Type: Article

References (40)

1. Ramchandran K, Patel JD (2009) Sex differences in susceptibility to carcinogens. Semin Oncol 36(6):516-523
2. Brinton LA, Gierach GL, Andaya A, Park Y, Schatzkin A, Hollenbeck AR, Spitz MR (2011) Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort. Cancer Epidemiol Biomarkers Prev 20(5):900-911
3. Chen KY, Hsiao CF, Chang GC, Tsai YH, Su WC, Perng RP, Huang MS, Hsiung CA, Chen CJ, Yang PC (2007) Hormone replacement therapy and lung cancer risk in Chinese. Cancer 110(8):1768-1775 (Pubitemid 47557301)
4. Kreuzer M, Gerken M, Heinrich J, Kreienbrock L, Wichmann HE (2003) Hormonal factors and risk of lung cancer among women? Int J Epidemiol 32(2):263-271 (Pubitemid 36622273)
5. Olsson H, Bladstrom A, Ingvar C (2003) Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy? Obstet Gynecol 102(3):565-570 (Pubitemid 37311223)
6. Ramnath N, Menezes RJ, Loewen G, Dua P, Eid F, Alkhaddo J, Paganelli G, Natarajan N, Reid ME (2007) Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study. Oncology 73(5-6):305-310 (Pubitemid 351862020)
7. Rodriguez C, Spencer FH, Deka A, Patel AV, Jacobs EJ, Thun MJ, Calle EE (2008) Postmenopausal hormone therapy and lung cancer risk in the Cancer Prevention Study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 17(3):655-660 (Pubitemid 351469216)
8. Schabath MB, Wu X, Vassilopoulou-Sellin R, Vaporciyan AA, Spitz MR (2004) Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res 10(1 Pt 1):113-123 (Pubitemid 38114169)
9. Schwartz AG, Wenzlaff AS, Prysak GM, Murphy V, Cote ML, Brooks SC, Skafar DF, Lonardo F (2007) Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J Clin Oncol 25(36):5785-5792
10. Marquez-Garban DC, Chen HW, Fishbein MC, Goodglick L, Pietras RJ (2007) Estrogen receptor signaling pathways in human non-small cell lung cancer. Steroids 72(2):135-143 (Pubitemid 46273500)
11. Baik CS, Strauss GM, Speizer FE, Feskanich D (2010) Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev 19(10):2525-2533
12. Blackman JA, Coogan PF, Rosenberg L, Strom BL, Zauber AG, Palmer JR, Langenberg P, Shapiro S (2002) Estrogen replacement therapy and risk of lung cancer. Pharmacoepidemiol Drug Saf 11(7):561-567 (Pubitemid 35345406)
13. Chlebowski RT, Anderson GL, Manson JE, Schwartz AG, Wakelee H, Gass M, Rodabough RJ, Johnson KC, Wactawski- Wende J, Kotchen JM, Ockene JK, O'Sullivan MJ et al (2010) Lung cancer among postmenopausal women treated with estrogen alone in the Women's Health Initiative randomized trial. J Natl Cancer Inst 102(18):1413-1421
14. Elliott AM, Hannaford PC (2006) Use of exogenous hormones by women and lung cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study. Contraception 73(4):331-335 (Pubitemid 43375089)
15. Chlebowski RT, Schwartz AG, Wakelee H, Anderson GL, Stefanick ML, Manson JE, Rodabough RJ, Chien JW, Wactawski- Wende J, Gass M, Kotchen JM, Johnson KC et al (2009) Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post hoc analysis of a randomised controlled trial. Lancet 374(9697):1243-1251
16. Kabat GC, Miller AB, Rohan TE (2007) Reproductive and hormonal factors and risk of lung cancer in women: a prospective cohort study. Int J Cancer 120(10):2214-2220 (Pubitemid 46555861)
17. Slatore CG, Chien JW, Au DH, Satia JA, White E (2010) Lung cancer and hormone replacement therapy: association in the Vitamins and Lifestyle Study. J Clin Oncol 28(9):1540-1546
18. Smith JR, Barrett-Connor E, Kritz-Silverstein D, Wingard DL, Al-Delaimy WK (2009) Hormone use and lung cancer incidence: the Rancho Bernardo Cohort Study. Menopause 16(5):1044-1048
19. Liu Y, Inoue M, Sobue T, Tsugane S (2005) Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study. Int J Cancer 117(4):662-666 (Pubitemid 41504556)
20. Taioli E, Wynder EL (1994) Re: endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 86(11): 869-870
21. Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, Hurwitz PE, Coyle L, Schussler N, Michaud DS, Freedman LS, Brown CC et al (2001) Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 154(12):1119-1125 (Pubitemid 33140635)
22. Michaud DS, Micthune D, Hermansen S et al (2005) Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Regist Manag 32:70-75
23. Fritz A, Percy C, Jack A, et al. (2000) International classification of diseases for oncology, 3 Geneva, Switzerland
24. Gail NH, Lubin JH, Rubinstein LV (1981) Likelihood calculations for matched case-control studies and survival studies with tied death times. Biometrika 68:703-707
25. Grimes DA, Schulz KF (2005) Compared to what? Finding controls for case-control studies. Lancet 365(9468):1429-1433 (Pubitemid 40523738)
26. Clague J, Reynolds P, Sullivan-Halley J, Ma H, Lacey JV Jr, Henderson KD, Ursin G, West DW, Chang S, Delclos G, Du XL, Forman MR, et al. (2011) Menopausal hormone therapy does not influence lung cancer risk: results from the California Teachers Study. Cancer Epidemiol Biomarkers Prev 20(3):560-564
27. Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L (1989) Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 44(5):833-839 (Pubitemid 20007980)
28. Kabat GC, Kim M, Hunt JR, Chlebowski RT, Rohan TE (2008) Body mass index and waist circumference in relation to lung cancer risk in the Women's Health Initiative. Am J Epidemiol 168(2):158-169 (Pubitemid 351951596)
29. Smith L, Brinton LA, Spitz MR, Lam TK, Park Y, Hollenbeck AR, Freedman ND, Gierach GL (2011) Body mass index and lung cancer risk among never, former, and current smokers. J Natl Cancer Inst (in press)
30. Oh SW, Myung SK, Park JY, Lym YL, Ju W (2010) Hormone therapy and risk of lung cancer: a meta-analysis. J Womens Health (Larchmt) 19(2):279-288
31. Marquez-Garban DC, Mah V, Alavi M, Maresh EL, Chen HW, Bagryanova L, Horvath S, Chia D, Garon E, Goodglick L, Pietras RJ (2011) Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer. Steroids 76(9): 910-920
32. Key TJ, Appleby PN, Reeves GK, Roddam AW, Helzlsouer KJ, Alberg AJ, Rollison DE, Dorgan JF, Brinton LA, Overvad K, Kaaks R, Trichopoulou A et al (2011) Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer 105(5):709-722
33. Freedman ND, Leitzmann MF, Hollenbeck AR, Schatzkin A, Abnet CC (2008) Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol 9(7):649-656
34. Siegfried JM, Hershberger PA, Stabile LP (2009) Estrogen receptor signaling in lung cancer. Semin Oncol 36(6):524-531
35. Beral V, Bull D, Reeves G (2005) Endometrial cancer and hormone- replacement therapy in the Million Women Study. Lancet 365(9470):1543-1551
36. Brinton LA, Richesson D, Leitzmann MF, Gierach GL, Schatzkin A, Mouw T, Hollenbeck AR, Lacey JV Jr (2008) Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Epidemiol Biomarkers Prev 17(11):3150-3160
37. Koushik A, Parent ME, Siemiatycki J (2009) Characteristics of menstruation and pregnancy and the risk of lung cancer in women. Int J Cancer 125(10):2428-2433
38. Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z, Shoupe D, Berek JS, Hankinson S, Manson JE (2009) Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses' Health Study. Obstet Gynecol 113(5): 1027-1037
39. Weiss JM, Lacey JV Jr, Shu XO, Ji BT, Hou L, Yang G, Li H, Rothman N, Blair A, Gao YT, Chow WH, Zheng W (2008) Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol 168(11): 1319-1325
40. Zatloukal P, Kubik A, Pauk N, Tomasek L, Petruzelka L (2003) Adenocarcinoma of the lung among women: risk associated with smoking, prior lung disease, diet and menstrual and pregnancy history. Lung Cancer 41(3):283-293 (Pubitemid 36970184)